MétaCan
Menu
Retour à la cohorte
Enregistrement W4417011103 · doi:10.1182/blood-2025-1991

Immune deconvolution from whole transcriptomic data suggests expansion of exhausted T-cells and natural killer cells following tyrosine kinase inhibitor therapy in chronic myeloid leukemia patients

2025· article· en· W4417011103 sur OpenAlexaff
Yael Morgenstern, Amirthagowri Ambalavanan, Jae-Sook Ahn, María Agustina Perusini, Flavia Patino, Danielle Pyne, Oyeronke Ayansola, Hyeoung Joon Kim, Dennis Kim

Notice bibliographique

RevueBlood · 2025
Typearticle
Langueen
DomaineMedicine
ThématiqueChronic Myeloid Leukemia Treatments
Établissements canadiensPrincess Margaret Cancer CentreUniversity Health Network
Organismes subventionnairesnon disponible
Mots-clésImmune systemMyeloid leukemiaNatural killer cellMyeloidCellBone marrowT cellMass cytometry

Résumé

récupéré en direct d'OpenAlex

Abstract Introduction Tyrosine kinase inhibitor (TKI) therapy, while targeting leukemic cells, also alters the immune landscape in chronic myeloid leukemia (CML). Notably, expansion of immune cell populations such as T- or NK-cells has been associated with achieving and maintaining treatment-free remission (TFR). Moreover, distinct exhausted T-cell (Tex) and NK cell (NKex) may affect TKI response and TFR durability. While multicolor flow-cytometry and single cell RNAseq (scRNAseq) are promising tools for exploring immune dynamics, these techniques are costly and require fresh samples limiting scalability. In contrast, immune cell deconvolution using bulk RNA sequencing (RNAseq) data offers a cost-effective alternative requiring less specialized expertise. This study aimed to apply immune cell deconvolution using bulk RNA sequencing data to characterize immune cell populations, particularly T-, NK-, Tex and NKex cells, and to evaluate correlation of these cell subpopulations with clinical outcomes of CML pts. Additionally, it assessed the feasibility of immune deconvolution in this context. Patients and method Paired bone marrow samples from diagnosis (dx) and follow up (FU) from 72 pts were sequenced using the Illumina TruSeq mRNA panel. ScRNAseq was performed on 3 bone marrow samples (CML diagnosis, post-TKI follow-up and healthy donor) using Chromium x10 scRNAseq. SingleR with the Monaco Immune Data reference was used to annotate data. Exhausted T and NK cells were identified based on expression of exhaustion gene markers (i.e. PDCD1, LAG3, TIM3, and TIGIT) within the total T cell and NK cell population. After validation of the Monaco Immune Data reference with the scRNAseq data, cell type proportions in bulk RNAseq samples were estimated using BisqueRNA deconvolution. Analysis focused on quantifying 10 immune cell types and 30 different subtypes across patient samples. Immune cell populations were compared pairwise (Dx vs. FU) between patient subgroups with optimal response (n=41) and those with resistance or disease progression (n=30; resistance: n=19, progression: n=13). Results The study included 72 CML pts (43% female, median age 58 years). At diagnosis, 64 pts (91%) were in chronic phase, with Sokal risk scores classified as high (n=11), intermediate (n=28), or low (n=33). Most pts received imatinib as first-line therapy (n=58, 83%), while 14 pts received (2G-TKIs). With a median follow-up of 1,740 days, the pts were classified into optimal response (n=40), resistance (n=19), or progression (n=13) according to their clinical outcomes. Analysis of T-cell abundance in CML pts at dx revealed a significant inverse correlation between proportion of T cells and Sokal risk group (Kruskal-Wallis p = 0.0094). Pts classified as high-risk had a lower mean T cell proportion (17.8%) compared to those in the intermediate-risk (19.6%) and low-risk (21.0%) groups. Deconvolution of the bulk RNAseq data revealed distinct immune cell composition patterns with elevated proportions of NK and T cells in Dx samples compared to FU, consistent with the immune profiles inferred from matched scRNAseq data. Specifically, Dx samples showed a marked increase in T cells (19.3% to 26.1%, p = 2.12 ×10⁻¹⁴), NK cells (1.7% to 5.1%, p = 1.36×10⁻⁷), central memory CD8⁺ T cells (0.38% to 1.29%, p = 5.67×10⁻⁵), follicular helper T cells (0.28% to 1.98%, p = 1.02×10⁻⁹), regulatory T cells (0.03% to 0.31%, p = 1.86×10⁻⁶), Th1 cells (0.004% to 2.3%, p = 4.5× 10⁻²⁰), and Th17 cells (0.23% to 1.29%, p = 1.74×10⁻⁹). Of interest, FU samples exhibited an increase in the populations of exhausted T- and NK-cells with expansion of Tex (1.79% vs. 0.51%, p=3.46 x 10-5) and NKex (0.48% vs. 0.24%, p=1.94x10-2). Interestingly, comparison of immune profiles between optimal responders and pts with resistance/ progression revealed no significant differences. Conclusion Immune deconvolution from bulk RNAseq is feasible to evaluate immune cell composition in CML pts. An inverse correlation between risk group and proportion of T cells was detected, suggesting enhanced T-cell immunity in lower disease risk. Notably, in contrast to previous studies, the proportion of Tex-cells increased significantly post-TKI therapy, supporting TKI may induce T-cell exhaustion rather than recover T-cell functions. Future studies using this method may clarify mechanisms of TKI-induced T- and NK-cell exhaustion and their impact on TFR.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,001
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: aucune
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,001
Score d'incertitude au seuil0,005

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0000,001
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0010,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,011
Tête enseignante GPT0,248
Écart entre enseignants0,237 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueBloodMême sujetChronic Myeloid Leukemia TreatmentsTravaux en français237 207